Navigenics

Frazier Healthcare Partners Announces Amy DuRoss as Senior Advisor

Retrieved on: 
Monday, August 1, 2022

Frazier Healthcare Partners, a leading private equity and venture capital firm focused exclusively on the healthcare industry, is pleased to announce that Amy DuRoss has joined the firms Growth Buyout team as a Senior Advisor.

Key Points: 
  • Frazier Healthcare Partners, a leading private equity and venture capital firm focused exclusively on the healthcare industry, is pleased to announce that Amy DuRoss has joined the firms Growth Buyout team as a Senior Advisor.
  • Amy is a great fit with our firms culture, and we are fortunate to have her as a Senior Advisor.
  • Founded in 1991, Frazier Healthcare Partners is a leading private equity firm focused exclusively on the healthcare sector.
  • For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com .

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Retrieved on: 
Monday, July 25, 2022

MONROE, Ohio, July 25, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today that Amy DuRoss has joined the company as President, Cell and Gene Therapies (CGT).

Key Points: 
  • Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development
    MONROE, Ohio, July 25, 2022 /PRNewswire/ -- CSafe Global , the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today that Amy DuRosshas joined the company as President, Cell and Gene Therapies (CGT).
  • In her new role, DuRosswill lead CSafe'sCGT solutions portfolio to support intelligent transport of high-value personalized therapies and vaccines to meet the unprecedented global supply chain transport complexity of CGT products.
  • Ms. DuRossbrings more than 25 years' experience to her new position.
  • She serves on the boards of Biolife Solutions (BLFS), MJH, Americans for Cures, and the ARM Foundation and is a member of the Aspen Institute Global Network.

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Retrieved on: 
Monday, July 25, 2022

MONROE, Ohio, July 25, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today that Amy DuRoss has joined the company as President, Cell and Gene Therapies (CGT).

Key Points: 
  • Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development
    MONROE, Ohio, July 25, 2022 /PRNewswire/ -- CSafe Global , the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today that Amy DuRosshas joined the company as President, Cell and Gene Therapies (CGT).
  • In her new role, DuRosswill lead CSafe'sCGT solutions portfolio to support intelligent transport of high-value personalized therapies and vaccines to meet the unprecedented global supply chain transport complexity of CGT products.
  • Ms. DuRossbrings more than 25 years' experience to her new position.
  • She serves on the boards of Biolife Solutions (BLFS), MJH, Americans for Cures, and the ARM Foundation and is a member of the Aspen Institute Global Network.

Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel

Retrieved on: 
Tuesday, May 5, 2020

Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the appointment Stephen Moore as General Counsel.

Key Points: 
  • Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the appointment Stephen Moore as General Counsel.
  • Mr. Moore joins Personalis after a decade at Pacific Biosciences (NASDAQ: PACB), where he served as General Counsel.
  • Prior to Pacific Biosciences, Mr. Moore was General Counsel at Navigenics, a consumer genomics company that was later acquired by Life Technologies (now part of Thermo Fisher Scientific).
  • I am pleased to join the Personalis team at this important time for the company, said Mr. Moore.

Thermo Fisher Scientific to Present at Cowen and Company's 40th Annual Healthcare Conference on March 2, 2020

Retrieved on: 
Monday, February 24, 2020

WALTHAM, Mass., Feb. 24, 2020 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at Cowen and Company's 40th Annual Healthcare Conference in Boston on Monday, March 2, 2020, at 11:20 a.m. (EST).

Key Points: 
  • WALTHAM, Mass., Feb. 24, 2020 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at Cowen and Company's 40th Annual Healthcare Conference in Boston on Monday, March 2, 2020, at 11:20 a.m. (EST).
  • You can access the webcast via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion.
  • Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 14, 2019

Retrieved on: 
Tuesday, May 7, 2019

WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the Wynn Las Vegas, Las Vegas, Nevada.

Key Points: 
  • WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the Wynn Las Vegas, Las Vegas, Nevada.
  • You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 13, 2019

Retrieved on: 
Monday, March 4, 2019

WALTHAM, Mass., March 4, 2019 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, at 8:00 a.m. (EDT) at the Loews Miami Hotel, Miami, Florida.

Key Points: 
  • WALTHAM, Mass., March 4, 2019 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, at 8:00 a.m. (EDT) at the Loews Miami Hotel, Miami, Florida.
  • You can access the live webcast of the presentation in the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Jefferies 2018 London Healthcare Conference on November 14, 2018

Retrieved on: 
Wednesday, October 31, 2018

WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018, at 10:40 a.m. (GMT) at the Waldorf Hilton, London, UK.

Key Points: 
  • WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018, at 10:40 a.m. (GMT) at the Waldorf Hilton, London, UK.
  • You can access the live webcast of the presentation in the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2018

Retrieved on: 
Tuesday, September 4, 2018

WALTHAM, Mass., Sept. 4, 2018 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York.

Key Points: 
  • WALTHAM, Mass., Sept. 4, 2018 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York.
  • You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.